Pharma Journalist - Page 26 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

China Approves Two Sanofi Drugs for Rare Blood Disorders

Pfizer Reports Strong Phase 3 Results for TUKYSA in HER2+ Breast Cancer

Zydus, Formycon Partner to Bring Keytruda Biosimilar to North America

FDA Grants Orphan Drug Status to Ajax’s AJ1-11095 for Myelofibrosis

Lilly Invests $6 Billion in Alabama Facility for Next-Generation Medicines

FDA Approves Amneal’s Epinephrine Vials for Emergency and Hospital Use

Pfizer, YaoPharma Partner on GLP-1 Drug for Weight Management

EU Approves Roche’s Gazyva for Advanced Lupus Nephritis Treatment

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Viatris Sells Biocon Biologics Stake for $815M in Strategic Shift